Cargando…

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial

BACKGROUND: In patients with a minor ischaemic stroke or transient ischaemic attack (TIA), separate trials have shown that dual antiplatelet therapy with clopidogrel plus aspirin (clopidogrel–aspirin) or ticagrelor plus aspirin (ticagrelor–aspirin) are more effective than aspirin alone in stroke sec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yongjun, Johnston, Claiborne, Bath, Philip M, Meng, Xia, Jing, Jing, Xie, Xuewei, Wang, Anxin, Pan, Yuesong, Xu, Anding, Dong, Qiang, Wang, Yilong, Zhao, Xingquan, Li, Zixiao, Li, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258075/ https://www.ncbi.nlm.nih.gov/pubmed/33952670 http://dx.doi.org/10.1136/svn-2020-000791

Ejemplares similares

Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial
por: Xie, Xuewei, et al.
Publicado: (2023)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack
por: Li, Zixiao, et al.
Publicado: (2016)

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
por: Pan, Yuesong, et al.
Publicado: (2022)

Clopidogrel Plus Aspirin in Patients With Different Types of Single Small Subcortical Infarction
por: Wang, Guangyao, et al.
Publicado: (2021)

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019)

Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack
por: Zhang, Jia, et al.
Publicado: (2023)

Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES)
por: Gao, Ying, et al.
Publicado: (2023)

Predictive Role of hsCRP in Recurrent Stroke Differed According to Severity of Cerebrovascular Disease: Analysis from a Prospective Cohort Study
por: Li, Jiejie, et al.
Publicado: (2023)

The design, rationale, and baseline characteristics of a nationwide cohort registry in China: blood pressure and clinical outcome in TIA or ischemic stroke
por: Xu, Jie, et al.
Publicado: (2016)

Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel
por: Ge, Lihong, et al.
Publicado: (2019)

Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
por: Karunawan, Niyata Hananta, et al.
Publicado: (2021)

Association of elevated hs-CRP and multiple infarctions with outcomes of minor stroke or TIA: subgroup analysis of CHANCE randomised clinical trial
por: Wang, Guangyao, et al.
Publicado: (2020)

Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry
por: Wang, Yongjun, et al.
Publicado: (2020)

Predictive Value of the ABCD3-I for Short- and Long-Term Stroke after TIA with or without sICAS
por: Xie, Xuewei, et al.
Publicado: (2022)

Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin
por: Wang, Peng, et al.
Publicado: (2020)

Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II
por: Yang, Ming, et al.
Publicado: (2019)

Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes
por: Chen, Huimin, et al.
Publicado: (2020)

Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)
por: Wang, Penglian, et al.
Publicado: (2012)

Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings
por: Wang, Yongjun, et al.
Publicado: (2018)

Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004)

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
por: Johnston, S Claiborne, et al.
Publicado: (2019)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack
por: Chen, Zimo, et al.
Publicado: (2020)

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
por: Wang, Yongjun, et al.
Publicado: (2019)

Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

Effect of Stress Hyperglycemia on Neurological Deficit and Mortality in the Acute Ischemic Stroke People With and Without Diabetes
por: Li, Jiejie, et al.
Publicado: (2020)

Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design
por: Li, Shuya, et al.
Publicado: (2021)

Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS
por: Li, Zixiao, et al.
Publicado: (2019)

Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
por: Xu, Jie, et al.
Publicado: (2019)

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
por: Wang, Yongjun, et al.
Publicado: (2022)

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial
por: Zhou, Mengyuan, et al.
Publicado: (2020)

The role of hypertension and diabetes mellitus on the etiology of middle cerebral artery disease
por: Zhang, Changqing, et al.
Publicado: (2022)

Posterior circulation stroke due to intracranial artery disease in the Chinese population
por: Zhang, Changqing, et al.
Publicado: (2022)

Intracranial artery stenosis magnetic resonance imaging aetiology and progression study: Rationale and design
por: Han, Yongjun, et al.
Publicado: (2018)

Clinical, imaging features and outcome in internal carotid artery versus middle cerebral artery disease
por: Zhang, Changqing, et al.
Publicado: (2019)

Asymptomatic Extracranial Artery Stenosis and the Risk of Cardiovascular and Cerebrovascular Diseases
por: Wang, Dandan, et al.
Publicado: (2016)

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial
por: Wang, Yongjun, et al.
Publicado: (2021)

Triglyceride Glucose Index and Prognosis of Patients With Ischemic Stroke
por: Zhou, Yimo, et al.
Publicado: (2020)

Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial
por: de Havenon, Adam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aeertl4bnio2ad1dee7liqr5j6